Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01557
|
|||||
| Drug Name |
Oxfendazole
|
|||||
| Synonyms |
Oxfendazole; Fenbendazole sulfoxide; Synanthic; Systamex; OFDZ; Systemax; Repidose; Oxfendazolum; Oxfendazol; Synanthic (Veterinary); RS-8858; fenbendazole S-oxide; RS 8858; 5-Phenylsulfinyl-2-carbomethoxyaminobenzimidazole; Oxfendazol [INN-Spanish]; Oxfendazolum [INN-Latin]; UNII-OMP2H17F9E; HOE 8105; methyl [5-(phenylsulfinyl)-1H-benzimidazol-2-yl]carbamate; Oxfendazole [USAN:BAN:INN]; Methyl 5-(phenylsulfinyl)-2-benzimidazolecarbamate; Oxfendazole (USP/INN)
|
|||||
| Indication | Trichuris infection [ICD11: 1F6G] | Phase 2 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H13N3O3S
|
|||||
| Canonical SMILES |
COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3
|
|||||
| InChI |
InChI=1S/C15H13N3O3S/c1-21-15(19)18-14-16-12-8-7-11(9-13(12)17-14)22(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,16,17,18,19)
|
|||||
| InChIKey |
BEZZFPOZAYTVHN-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 53716-50-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 315.3 | Topological Polar Surface Area | 103 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
2.3
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:35812
|
|||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT03435718) Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults | |||||
| 2 | Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2). Drug Metab Dispos. 2005 May;33(5):614-8. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.